GTS Securities’s Repligen RGEN Stock Holding History

GTS Securities’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,513	Closed	-$320K	–	1529
2025 Q1	$320K	Buy	2,513 +680	+37%	+$105K	0.01%	909
2024 Q4	$264K	Buy	+1,833	New	+$263K	0.01%	965

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

GTS Securities's RGEN Position: Q2 2025 in Review

GTS Securities sold out of Repligen (RGEN) in Q2 2025, closing a stake of 2,513 shares — an estimated $320K sold.

GTS Securities first reported a position in RGEN in Q4 2024 and held it in 2 quarters. The position peaked at $320K in Q1 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

GTS Securities reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
GTS Securities sold 2,513 Repligen shares in Q2 2025, an estimated $320K.
GTS Securities first reported a position in Repligen in Q4 2024 and held it in 2 quarters.
GTS Securities's Repligen position peaked at $320K in Q1 2025.
444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.